Alcami appoints new CEO in Patrick Walsh, the executive who helped lead the CDMO's predecessor company
While North Carolina-based Alcami only came into existence back in 2016, the company has looked to keep expanding as the market for contract work in biopharma continues to grow. To get it there, it’s tapping an old friend — the executive who helped chart the company on its current path.
Alcami named Patrick Walsh as its newest CEO on March 18. Walsh previously served as CEO of AAI Pharma, the predecessor company that eventually became Alcami, between 2010 and 2014.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 106,500+ biopharma pros reading Endpoints daily — and it's free.